Neuron23

Series-B+
neuron23.com Biotech & Healthcare South San Francisco, United States 11-50
Total Funding $197M
Latest Round $97M Series-B+
Last Announced Jun 24, 2025
Investors 12 Backers
Decision Makers 5 Verified

About Neuron23

Neuron23 is developing a precision medicine approach designed to improve the lives of people with Parkinson’s disease.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters South San Francisco, United States
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website neuron23.com
Domain Registered Date Aug 8, 2018

Social & Network Presence

X / Twitter Profile @official_N23 (132 followers) Created on Dec 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $97,000,000 · Series-B+

    startupintros.com

  2. Capital Raise

    Raised $100,000,000 · Series-B+

    fundraisingfox.com

  3. Milestone

    X account created (@official_N23)

    132 followers

  4. Milestone

    Website domain registered

    neuron23.com

Investors & Backers

12
Acorn Bioventures
Blue Owl Capital
Cowen Healthcare Investments
HBM Healthcare Investments
HBM Partners
Kleiner Perkins
Michael J. Fox Foundation
Perceptive Advisors
Redmile Group
SoftBank Vision Fund
Surveyor Capital
Westlake Village BioPartners

Funding History

2 Rounds
Series-B+ · Jun 24, 2025
Series-B+ · Mar 30, 2022

Founders & Leadership

5

Adam Knight

Founder

Work email & phone locked Unlock →

Andrew Yost

Chief Business Officer

Work email & phone locked Unlock →

Marcel van der Brug

VP Genetics and Data Sciences

Work email & phone locked Unlock →

Nancy Stagliano

Chief Executive Office

Work email & phone locked Unlock →

Sam Jackson

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts